Venus Concept Inc. to Present at the Stifel 2020 Virtual Healthcare Conference
Venus Concept (NASDAQ: VERO) announced its participation in the Stifel 2020 Virtual Healthcare Conference, set for November 16th at 4:00 p.m. ET. The event highlights the company’s innovative medical aesthetic technologies, including their subscription-based sales model in North America and global markets. Interested parties can access a live audio webcast of the presentation on the Company’s investor relations website, with a replay available afterward. Venus Concept has a diverse portfolio, featuring aesthetic and hair restoration technologies, operating in over 60 countries.
- None.
- None.
TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2020 Virtual Healthcare Conference. Management will present on Monday, November 16th at 4:00 p.m. Eastern Time.
A live audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 26 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
FAQ
When will Venus Concept present at the Stifel 2020 Virtual Healthcare Conference?
How can I access the Venus Concept presentation at the Stifel conference?
What technologies does Venus Concept offer?
What is the stock symbol for Venus Concept?